Figure 1.
Salmonella combination vaccine pipeline including licensed and World Health Organization–prequalified typhoid conjugate vaccines, monovalent paratyphoid A vaccines in clinical development, and potential quadrivalent Salmonella vaccines. Arrowed boxes indicate ongoing development. Abbreviations: 1V, monovalent; 2V, bivalent; 3V, trivalent; 4V, quadrivalent; BBIL, Bharat Biotech International Ltd; BCH, Boston Children's Hospital; BioE, Biological E; GMMA, generalized modules for membrane antigens; GVGH, GlaxoSmithKline Vaccines Institute for Global Health; IVI, International Vaccine Institute; LIBP, Lanzhou Institute of Biological Products; NIH, National Institutes of Health; NTS, nontyphoidal Salmonella; PQ, prequalified; SEn, Salmonella Enteritidis; STm, Salmonella Typhimurium; SII, Serum Institute of India; TCV, typhoid conjugate vaccine; UMD, University of Maryland; WHO, World Health Organization.